Potential conflict of interest: Nothing to report.
Steatohepatitis/Metabolic Liver Disease
Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice
Article first published online: 27 MAR 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 5, pages 1791–1802, May 2014
How to Cite
Han, S.-i., Komatsu, Y., Murayama, A., Steffensen, K. R., Nakagawa, Y., Nakajima, Y., Suzuki, M., Oie, S., Parini, P., Vedin, L.-L., Kishimoto, H., Shimano, H., Gustafsson, J.-Å. and Yanagisawa, J. (2014), Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice. Hepatology, 59: 1791–1802. doi: 10.1002/hep.26951
This work was supported by the Research Fellowship (to S.H. and Y.K.) from the Japan Society for the Promotion of Science. J-A.G. was supported by the Swedish Cancer Society, the Texas Emerging Technology Fund (under Agreement 18, no. 300-9-1958), and the Robert A. Welch Foundation (E-0004).
- Issue published online: 23 APR 2014
- Article first published online: 27 MAR 2014
- Accepted manuscript online: 26 NOV 2013 03:25AM EST
- Manuscript Accepted: 19 NOV 2013
- Manuscript Received: 10 JAN 2013